Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Mgodi NM"'
Autor:
Dandadzi A; University of Zimbabwe-Clinical Trials Research Centre, Harare, Zimbabwe. adandadzi@uz-ctrc.org., Young AM; Women's Global Health Imperative, RTI International, Berkeley, CA, USA.; Department of Maternal and Child Health, University of North Carolina, Chapel Hill, NC, USA., Musara P; University of Zimbabwe-Clinical Trials Research Centre, Harare, Zimbabwe., Shapley-Quinn MK; Women's Global Health Imperative, RTI International, Berkeley, CA, USA., Kemigisha D; Makerere University-Johns Hopkins Research Collaboration, Kampala, Uganda., Mutero P; University of Zimbabwe-Clinical Trials Research Centre, Harare, Zimbabwe., Mgodi NM; University of Zimbabwe-Clinical Trials Research Centre, Harare, Zimbabwe., Etima J; Makerere University-Johns Hopkins Research Collaboration, Kampala, Uganda., Minnis AA; Women's Global Health Imperative, RTI International, Berkeley, CA, USA.
Publikováno v:
BMC public health [BMC Public Health] 2024 Jul 15; Vol. 24 (1), pp. 1876. Date of Electronic Publication: 2024 Jul 15.
Autor:
Siziba B; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe., Mgodi NM; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe., Ngara B; University of Zimbabwe College of Health Sciences, Harare, Zimbabwe., Chawana TD; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe., Chitukuta M; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe., Mukwekwerere PG; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe., Bhondai-Mhuri M; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe., Chirenje ZM; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe.; University of California San Francisco, San Francisco, California, USA., Mhlanga FGS; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe.
Publikováno v:
BMJ public health [BMJ Public Health] 2024 Jul; Vol. 2 (1). Date of Electronic Publication: 2024 Apr 16.
Autor:
Stalter RM; Department of Epidemiology, University of Washington, Seattle, WA, USA., Dong TQ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Hendrix CW; Department of Medicine, Johns Hopkins University, Baltimore, MD, USA., Palanee-Phillips T; Department of Epidemiology, University of Washington, Seattle, WA, USA.; Wits Reproductive Health and HIV Research Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., van der Straten A; Center for AIDS Prevention Studies, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.; ASTRA consulting, Kensington, CA, USA., Hillier SL; Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Magee-Womens Research Institute, Pittsburgh, PA, USA., Kiweewa FM; Research Department, Makerere University-Johns Hopkins University Research Collaboration, Kampala, Uganda., Mgodi NM; Clinical Trials Research Centre, University of Zimbabwe, Harare, Zimbabwe., Marzinke MA; Department of Medicine, Johns Hopkins University, Baltimore, MD, USA., Bekker LG; The Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa., Soto-Torres L; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Baeten JM; Department of Epidemiology, University of Washington, Seattle, WA, USA.; Departments of Medicine and Global Health, University of Washington, Seattle, WA, USA., Brown ER; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Department of Biostatistics, University of Washington, Seattle, WA, USA.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2024 Apr 12; Vol. 229 (4), pp. 1158-1165.
Autor:
Moodie Z; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Andersen-Nissen E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa., Grunenberg N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Dintwe OB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa., Omar FL; Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa., Kee JJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Bekker LG; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa., Laher F; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Naicker N; Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa; and Department of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa., Jani I; Instituto Nacional de Saude, Maputo, Mozambique., Mgodi NM; Clinical Trials Research Centre, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe., Hunidzarira P; Clinical Trials Research Centre, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe., Sebe M; Aurum Institute, Tembisa, Gauteng, South Africa., Miner MD; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Polakowski L; DAIDS, NIAID, NIH, Bethesda, Maryland, United States of America., Ramirez S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Nebergall M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Takuva S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Sikhosana L; Hutchinson Centre Research Institute of South Africa, Johannesburg, South Africa., Heptinstall J; Department of Surgery, Duke University, Durham, North Carolina, United States of America., Seaton KE; Department of Surgery, Duke University, Durham, North Carolina, United States of America., De Rosa S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Diazgranados CA; Formerly Sanofi-Pasteur, Swiftwater, Pennsylvania, Pennsylvania, United States of America., Koutsoukos M; GSK, Wavre, Belgium., Van Der Meeren O; Previously GSK, Rixensart, Belgium., Barnett SW; Bill & Melinda Gates Foundation, Seattle, Washington, United States of America., Kanesa-Thasan N; Formerly GSK, Rockville, Maryland, United States of America., Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Tomaras GD; Department of Surgery, Duke University, Durham, North Carolina, United States of America., McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Mngadi K; Aurum Institute, Tembisa, Gauteng, South Africa., Goepfert P; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Publikováno v:
PLoS medicine [PLoS Med] 2024 Mar 19; Vol. 21 (3), pp. e1004360. Date of Electronic Publication: 2024 Mar 19 (Print Publication: 2024).
Autor:
Friedland BA; Population Council, Center for Biomedical Research, New York, New York, USA Bfriedland@popcouncil.org., Mgodi NM; University of Zimbabwe - Clinical Trials Research Centre, Harare, Zimbabwe., Palanee-Phillips T; Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Faculty of Health Sciences, School of Public Health, Johannesburg, South Africa.; University of Washington, Department of Epidemiology, School of Public Health, Seattle, Washington, USA., Mathur S; Population Council, Washington, District of Columbia, USA., Plagianos MG; Population Council, Center for Biomedical Research, New York, New York, USA., Bruce IV; Population Council, Center for Biomedical Research, New York, New York, USA., Lansiaux M; Population Council, Center for Biomedical Research, New York, New York, USA., Murombedzi C; University of Zimbabwe - Clinical Trials Research Centre, Harare, Zimbabwe., Musara P; University of Zimbabwe - Clinical Trials Research Centre, Harare, Zimbabwe., Dandadzi A; University of Zimbabwe - Clinical Trials Research Centre, Harare, Zimbabwe., Reddy K; Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Faculty of Health Sciences, School of Public Health, Johannesburg, South Africa., Ndlovu N; Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Faculty of Health Sciences, School of Public Health, Johannesburg, South Africa., Zulu SK; Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Faculty of Health Sciences, School of Public Health, Johannesburg, South Africa., Shale LR; Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Faculty of Health Sciences, School of Public Health, Johannesburg, South Africa., Zieman B; Population Council, Center for Biomedical Research, New York, New York, USA., Haddad LB; Population Council, Center for Biomedical Research, New York, New York, USA.
Publikováno v:
BMJ open [BMJ Open] 2024 Mar 12; Vol. 14 (3), pp. e075381. Date of Electronic Publication: 2024 Mar 12.
Autor:
Parikh UM; University of Pittsburgh, PA., Penrose KJ; University of Pittsburgh, PA., Heaps AL; University of Pittsburgh, PA., Sethi R; University of Pittsburgh, PA., Goetz BJ; University of Pittsburgh, PA., Szydlo D; Fred Hutchinson Cancer Research Center, Seattle, WA., Chandran U; University of Pittsburgh, PA., Palanee-Phillips T; Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa.; University of Washington, WA.; Currently, Gilead Sciences, Foster City, CA; and., Mgodi NM; University of Zimbabwe, Harare, Zimbabwe., Baeten JM; University of Washington, WA.; Currently, Gilead Sciences, Foster City, CA; and., Mellors JW; University of Pittsburgh, PA.
Publikováno v:
Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2024 Jan 01; Vol. 95 (1), pp. 35-41.
Autor:
Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA. yunda@fredhutch.org.; Department of Global Health, University of Washington, Seattle, WA, 98196, USA. yunda@fredhutch.org., Zhang L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA., Karuna S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA., Andrew P; Family Health International, Durham, NC, 27710, USA., Juraska M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA., Weiner JA; Thayer School of Engineering, Dartmouth College, Hanover, NH, 03755, USA., Angier H; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA., Morgan E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA., Azzam Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA., Swann E; Vaccine Research Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Rockville, MD, 46340, USA., Edupuganti S; Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, 30322, USA., Mgodi NM; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe., Ackerman ME; Thayer School of Engineering, Dartmouth College, Hanover, NH, 03755, USA., Donnell D; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA., Gama L; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Anderson PL; Colorado Antiviral Pharmacology Laboratory and Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado-AMC, Aurora, CO, 80045, USA., Koup RA; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Hural J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA., Cohen MS; Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA.; Departments of Medicine and Laboratory Medicine, University of Washington, Seattle, WA, 98195, USA., McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA.; Department of Global Health, University of Washington, Seattle, WA, 98196, USA.; Departments of Medicine and Laboratory Medicine, University of Washington, Seattle, WA, 98195, USA., Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA.; Department of Biostatistics, University of Washington, Seattle, WA, 98195, USA., Lemos MP; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA.
Publikováno v:
Nature communications [Nat Commun] 2023 Nov 28; Vol. 14 (1), pp. 7813. Date of Electronic Publication: 2023 Nov 28.
Autor:
Murombedzi C; Faculty of Medicine and Health Sciences, University of Zimbabwe, Clinical Trial Research Centre, Harare, Zimbabwe., Chirinda L; Pharmacovigilance and Clinical Trials Division, Medicines Control Authority of Zimbabwe, Harare, Zimbabwe., Chareka GT; Faculty of Medicine and Health Sciences, University of Zimbabwe, Clinical Trial Research Centre, Harare, Zimbabwe., Chirenje ZM; School of Medicine, University of California San Francisco, San Francisco, CA, United States., Mgodi NM; Faculty of Medicine and Health Sciences, University of Zimbabwe, Clinical Trial Research Centre, Harare, Zimbabwe.
Publikováno v:
Frontiers in reproductive health [Front Reprod Health] 2023 Nov 14; Vol. 5, pp. 1279124. Date of Electronic Publication: 2023 Nov 14 (Print Publication: 2023).
Autor:
Moore M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. jrmoore@fredhutch.org.; HPTN Modelling Centre, Imperial College London, London, UK. jrmoore@fredhutch.org., Stansfield S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; HPTN Modelling Centre, Imperial College London, London, UK., Donnell DJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Boily MC; HPTN Modelling Centre, Imperial College London, London, UK.; Medical Research Council Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK., Mitchell KM; HPTN Modelling Centre, Imperial College London, London, UK.; Medical Research Council Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK., Anderson PL; Anschutz Medical Campus, University of Colorado, Aurora, CO, USA., Delany-Moretlwe S; Wits RHI, University of Witwatersrand, Johannesburg, South Africa., Bekker LG; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa., Mgodi NM; College of Health Sciences Clinical Trials Research Centre, University of Zimbabwe, Harare, Zimbabwe., Celum CL; Departments of Global Health, Medicine and Epidemiology, University of Washington, Seattle, WA, USA., Dimitrov D; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; HPTN Modelling Centre, Imperial College London, London, UK.; Department of Applied Mathematics, University of Washington, Seattle, WA, USA.
Publikováno v:
Nature medicine [Nat Med] 2023 Nov; Vol. 29 (11), pp. 2748-2752. Date of Electronic Publication: 2023 Oct 05.
Autor:
Mgodi NM; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe., Murewanhema G; Unit of Obstetrics and Gynecology, Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe., Moyo E; Medical Centre, Oshakati, Namibia., Samba C; GALZ, Harare, Zimbabwe., Musuka G; International Initiative for Impact Evaluation, Harare, Zimbabwe., Dzinamarira T; School of Health Systems and Public Health, University of Pretoria, Pretoria, 0084, South Africa., Brown JM; Department of Epidemiology & Biostatistics, University of California San Francisco School of Medicine, San Francisco, California, 94158, USA.
Publikováno v:
Journal of the International AIDS Society [J Int AIDS Soc] 2023 Jul; Vol. 26 Suppl 2, pp. e26115.